HAMAMELIS VIRGINIANA

HAMAMELIS VIRGINIANA was reported 3902 times

HAMAMELIS VIRGINIANA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
1 ANORECTAL CELLULITIS 1 0.0164
2 HEPATIC ENZYME 2 0.0134
3 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 15 0.0072
4 X-RAY ABNORMAL 12 0.0067
5 DISLOCATION OF VERTEBRA 15 0.0066
6 HYPOCHOLESTEROLAEMIA 2 0.0057
7 SWOLLEN JOINT COUNT INCREASED 13 0.0041
8 PUSTULAR PSORIASIS 14 0.0041
9 RHEUMATIC FEVER 15 0.0034
10 RASH VESICULAR 14 0.0029
11 RHEUMATOID FACTOR POSITIVE 13 0.0022
12 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 14 0.0022
13 GRIP STRENGTH DECREASED 18 0.0020
14 WALKING AID USER 13 0.0020
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 14 0.0020
16 DUODENAL ULCER PERFORATION 14 0.0019
17 MUSCLE INJURY 15 0.0018
18 BREAST CANCER STAGE II 15 0.0018
19 HYPERCHOLESTEROLAEMIA 17 0.0018
20 GENERAL SYMPTOM 13 0.0017
21 HELICOBACTER INFECTION 17 0.0017
22 LUPUS VULGARIS 2 0.0016
23 MYOSITIS 14 0.0016
24 DEEP VEIN THROMBOSIS POSTOPERATIVE 3 0.0015
25 FOLLICULITIS 15 0.0014
26 HAND DEFORMITY 17 0.0013
27 GLIOBLASTOMA MULTIFORME 1 0.0012
28 WOUND INFECTION 13 0.0012
29 PEMPHIGUS 14 0.0011
30 C-REACTIVE PROTEIN 1 0.0011
31 JOINT RANGE OF MOTION DECREASED 14 0.0010
32 PERICARDITIS 15 0.0009
33 BACK DISORDER 14 0.0009
34 GLOSSODYNIA 18 0.0008
35 HIP ARTHROPLASTY 12 0.0008
36 PULMONARY FIBROSIS 15 0.0008
37 SYNOVITIS 13 0.0007
38 IRRITABLE BOWEL SYNDROME 15 0.0007
39 PORPHYRIA ACUTE 1 0.0007
40 EYE INJURY 2 0.0007
41 IMPAIRED HEALING 20 0.0006
42 DISABILITY 12 0.0006
43 FIBROMYALGIA 14 0.0006
44 LIVER INJURY 14 0.0006
45 KNEE ARTHROPLASTY 12 0.0006
46 PERIPHERAL VENOUS DISEASE 2 0.0005
47 ONYCHOMADESIS 2 0.0005
48 GAIT INABILITY 15 0.0004
49 DELIRIUM 15 0.0004
50 WOUND 12 0.0004
51 TYPE 2 DIABETES MELLITUS 14 0.0004
52 EYE OEDEMA 1 0.0004
53 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
54 APLASTIC ANAEMIA 2 0.0004
55 PSORIATIC ARTHROPATHY 15 0.0004
56 DRUG TOLERANCE DECREASED 1 0.0004
57 INFUSION SITE REACTION 1 0.0003
58 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
59 ILL-DEFINED DISORDER 20 0.0003
60 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
61 FACET JOINT SYNDROME 1 0.0003
62 BLOOD CHOLESTEROL INCREASED 14 0.0003
63 BONE EROSION 1 0.0003
64 OEDEMA 15 0.0003
65 FLUID RETENTION 14 0.0003
66 BLISTER 15 0.0003
67 HEPATIC CIRRHOSIS 5 0.0003
68 ARTHROPATHY 14 0.0003
69 HEPATIC ENZYME INCREASED 17 0.0002
70 BLEPHARITIS 1 0.0002
71 STOMATITIS 15 0.0002
72 DISCOMFORT 15 0.0002
73 WHEEZING 14 0.0002
74 AMNESIA 15 0.0002
75 INJURY 16 0.0002
76 SUSPECTED OFF LABEL USE 1 0.0002
77 GASTROINTESTINAL DISORDER 19 0.0002
78 INFUSION RELATED REACTION 14 0.0002
79 AUTOIMMUNE DISORDER 2 0.0002
80 SLEEP DISORDER 14 0.0002
81 MOBILITY DECREASED 14 0.0002
82 NORMAL NEWBORN 1 0.0002
83 BACK INJURY 2 0.0002
84 ASTHENOPIA 1 0.0002
85 PERIORBITAL SWELLING 1 0.0002
86 CONTUSION 16 0.0002
87 BURSITIS 2 0.0002
88 MUSCULOSKELETAL STIFFNESS 14 0.0002
89 BLEPHAROSPASM 1 0.0002
90 FOREIGN BODY SENSATION IN EYES 1 0.0002
91 PROCTALGIA 1 0.0002
92 BREAST CANCER STAGE III 1 0.0002
93 TASTE DISORDER 3 0.0001
94 ULCER HAEMORRHAGE 1 0.0001
95 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
96 MIGRAINE 14 0.0001
97 DYSPEPSIA 14 0.0001
98 LYMPHOPENIA 2 0.0001
99 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
100 SWELLING 13 0.0001
101 SINUSITIS 14 0.0001
102 CONGENITAL ANOMALY 1 0.0001
103 SCIATICA 2 0.0001
104 LIVE BIRTH 1 0.0001
105 JOINT SWELLING 14 0.0001
106 RHEUMATOID ARTHRITIS 13 0.0001
107 NAIL DISORDER 1 0.0001
108 INFECTION 16 0.0001
109 LUPUS-LIKE SYNDROME 1 0.0001
110 LIP DRY 1 0.0001
111 EXOSTOSIS 1 0.0001
112 BREAST CANCER STAGE I 1 0.0001
113 PSORIASIS 14 0.0001
114 LEUKAEMIA 1 0.0001
115 PERIPHERAL SWELLING 16 0.0001
116 EAR PAIN 2 0.0001
117 HAEMORRHOIDS 2 0.0001
118 MEMORY IMPAIRMENT 14 0.0001
119 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
120 HYPERSENSITIVITY 18 0.0001
121 HYPOAESTHESIA 14 0.0001
122 LIVER FUNCTION TEST INCREASED 2 0.0001
123 CONFUSIONAL STATE 15 0.0001
124 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
125 FOOT DEFORMITY 1 0.0001
126 HYPERTENSIVE CRISIS 1 0.0001
127 URTICARIA 15 0.0001
128 ALOPECIA 17 0.0001
129 HYPERTENSION 18 0.0001
130 ABDOMINAL DISCOMFORT 14 0.0001
131 CHEST PAIN 15 0.0001
132 JOINT STIFFNESS 2 0.0001
133 NASOPHARYNGITIS 14 0.0001
134 IMPAIRED GASTRIC EMPTYING 1 0.0001
135 DECREASED APPETITE 17 0.0001
136 GAIT DISTURBANCE 14 0.0001
137 OSTEOARTHRITIS 3 0.0001
138 MYELODYSPLASTIC SYNDROME 1 0.0001
139 ANOSMIA 1 0.0001
140 ABDOMINAL PAIN UPPER 14 0.0001
141 OBESITY 1 0.0001
142 WEIGHT INCREASED 14 0.0001
143 DEPRESSION 14 0.0001
144 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
145 CONJUNCTIVITIS 1 0.0001
146 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
147 LOWER LIMB FRACTURE 1 0.0001
148 PRESCRIBED OVERDOSE 1 0.0001
149 PRESCRIBED UNDERDOSE 1 0.0001
150 PREGNANCY 1 0.0000
151 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
152 BONE MARROW FAILURE 1 0.0000
153 ROAD TRAFFIC ACCIDENT 2 0.0000
154 PAIN IN EXTREMITY 14 0.0000
155 WEIGHT DECREASED 13 0.0000
156 RECTAL HAEMORRHAGE 2 0.0000
157 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
158 CONDITION AGGRAVATED 14 0.0000
159 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
160 PYREXIA 15 0.0000
161 PNEUMONIA 14 0.0000
162 PRODUCT PRESCRIBING ERROR 1 0.0000
163 PRURITUS 15 0.0000
164 ANAPHYLACTIC SHOCK 1 0.0000
165 INFLAMMATION 2 0.0000
166 MUSCULOSKELETAL PAIN 2 0.0000
167 EAR INFECTION 1 0.0000
168 FREQUENT BOWEL MOVEMENTS 1 0.0000
169 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
170 MEDICATION ERROR 2 0.0000
171 TARDIVE DYSKINESIA 1 0.0000
172 RASH 15 0.0000
173 MALAISE 15 0.0000
174 ARTHRALGIA 14 0.0000
175 RESPIRATORY DISORDER 1 0.0000
176 EPILEPSY 1 0.0000
177 ADVERSE EVENT 3 0.0000
178 DRUG-INDUCED LIVER INJURY 1 0.0000
179 NIGHT SWEATS 1 0.0000
180 HEADACHE 19 0.0000
181 FEBRILE NEUTROPENIA 2 0.0000
182 DYSPNOEA 17 0.0000
183 EYE PRURITUS 1 0.0000
184 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
185 VOMITING 13 0.0000
186 C-REACTIVE PROTEIN INCREASED 1 0.0000
187 THROMBOCYTOPENIA 3 0.0000
188 ASTHMA 3 0.0000
189 PAIN 16 0.0000
190 OSTEOPOROSIS 1 0.0000
191 DIARRHOEA 15 0.0000
192 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
193 LIVER DISORDER 1 0.0000
194 COLITIS ULCERATIVE 1 0.0000
195 ADVERSE DRUG REACTION 2 0.0000
196 THERAPY NON-RESPONDER 1 0.0000
197 FATIGUE 17 0.0000
198 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
199 DRUG INTOLERANCE 2 0.0000
200 LUNG DISORDER 1 0.0000
201 DRY EYE 1 0.0000
202 CELLULITIS 1 0.0000
203 NECK PAIN 1 0.0000
204 NAUSEA 14 0.0000
205 EYE IRRITATION 1 0.0000
206 ABDOMINAL PAIN 4 0.0000
207 PLEURAL EFFUSION 1 0.0000
208 FEELING HOT 1 0.0000
209 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
210 EXPOSURE DURING PREGNANCY 1 0.0000
211 PRODUCT QUALITY ISSUE 2 0.0000
212 INJECTION SITE REACTION 1 0.0000
213 UNDERDOSE 1 0.0000
214 BRONCHITIS 1 0.0000
215 EPISTAXIS 1 0.0000
216 HOSPITALISATION 2 0.0000
217 ARTHRITIS 1 0.0000
218 PARAESTHESIA 2 0.0000
219 THROMBOSIS 1 0.0000
220 DRY MOUTH 1 0.0000
221 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
222 TREATMENT FAILURE 1 0.0000
223 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
224 PRODUCT USE ISSUE 2 0.0000
225 ANXIETY 3 0.0000
226 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
227 MUSCULAR WEAKNESS 1 0.0000
228 VISUAL IMPAIRMENT 1 0.0000
229 LOSS OF CONSCIOUSNESS 1 0.0000
230 INSOMNIA 2 0.0000
231 DEHYDRATION 1 0.0000
232 VISION BLURRED 1 0.0000
233 OFF LABEL USE 5 0.0000
234 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
235 NO ADVERSE EVENT 1 0.0000
236 MUSCLE SPASMS 1 0.0000
237 INCORRECT DOSE ADMINISTERED 1 0.0000
238 FALL 1 0.0000
239 ASTHENIA 1 0.0000
240 DEATH 2 0.0000
241 DRUG INEFFECTIVE 3 0.0000
242 DIZZINESS 1 0.0000